Update in sepsis and pulmonary infections 2013

Richard G. Wunderink, Keith R. Walley*

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Journal has been in the vanguard of publications of the respiratory microbiome, including a National Institutes of Health Workshop report, establishing the normal microbiome in patients with various risks, and in the correlation of microbiome changes with disease exacerbations and lung transplant. A new classification scheme for healthcare-associated pneumonia, risks for nosocomial Pseudomonas pneumonia, and associations between communityacquired pneumonia and risks or outcomes have been reported. The increasingly recognized role of viral respiratory tract infections was reflected in publications regarding incidence rates, risk factors, and associations with other respiratory diseases. Significant contributions to understanding and treating sepsis emerged in 2013. The role of tissue damage was highlighted in a series of publications. A much greater understanding of the importance of pathways that directly impact the pathogen at the site of infection and subsequent pathogen clearance has emerged. The Journal published important contributions across the spectrum of ineffective therapy (activated protein C), novel therapeutic ideas (statins and extracorporeal membrane oxygenation), and solidly beneficial approaches (early protocolized care). Biomarker development is maturing to include a wide array of molecular measurements increasingly aimed at aiding improved therapy.

Original languageEnglish (US)
Pages (from-to)25-31
Number of pages7
JournalAmerican journal of respiratory and critical care medicine
Volume190
Issue number1
DOIs
StatePublished - Jul 1 2014

Fingerprint

Microbiota
Publications
Sepsis
Pneumonia
Lung
Infection
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Extracorporeal Membrane Oxygenation
National Institutes of Health (U.S.)
Pseudomonas
Protein C
Respiratory Tract Infections
Disease Progression
Therapeutics
Biomarkers
Delivery of Health Care
Transplants
Education
Incidence

Keywords

  • Biomarkers
  • Microbiome
  • Pneumonia
  • Sepsis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

@article{3402ca31887e4be1ab6767130a78481b,
title = "Update in sepsis and pulmonary infections 2013",
abstract = "The Journal has been in the vanguard of publications of the respiratory microbiome, including a National Institutes of Health Workshop report, establishing the normal microbiome in patients with various risks, and in the correlation of microbiome changes with disease exacerbations and lung transplant. A new classification scheme for healthcare-associated pneumonia, risks for nosocomial Pseudomonas pneumonia, and associations between communityacquired pneumonia and risks or outcomes have been reported. The increasingly recognized role of viral respiratory tract infections was reflected in publications regarding incidence rates, risk factors, and associations with other respiratory diseases. Significant contributions to understanding and treating sepsis emerged in 2013. The role of tissue damage was highlighted in a series of publications. A much greater understanding of the importance of pathways that directly impact the pathogen at the site of infection and subsequent pathogen clearance has emerged. The Journal published important contributions across the spectrum of ineffective therapy (activated protein C), novel therapeutic ideas (statins and extracorporeal membrane oxygenation), and solidly beneficial approaches (early protocolized care). Biomarker development is maturing to include a wide array of molecular measurements increasingly aimed at aiding improved therapy.",
keywords = "Biomarkers, Microbiome, Pneumonia, Sepsis",
author = "Wunderink, {Richard G.} and Walley, {Keith R.}",
year = "2014",
month = "7",
day = "1",
doi = "10.1164/rccm.201403-0577UP",
language = "English (US)",
volume = "190",
pages = "25--31",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

Update in sepsis and pulmonary infections 2013. / Wunderink, Richard G.; Walley, Keith R.

In: American journal of respiratory and critical care medicine, Vol. 190, No. 1, 01.07.2014, p. 25-31.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Update in sepsis and pulmonary infections 2013

AU - Wunderink, Richard G.

AU - Walley, Keith R.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - The Journal has been in the vanguard of publications of the respiratory microbiome, including a National Institutes of Health Workshop report, establishing the normal microbiome in patients with various risks, and in the correlation of microbiome changes with disease exacerbations and lung transplant. A new classification scheme for healthcare-associated pneumonia, risks for nosocomial Pseudomonas pneumonia, and associations between communityacquired pneumonia and risks or outcomes have been reported. The increasingly recognized role of viral respiratory tract infections was reflected in publications regarding incidence rates, risk factors, and associations with other respiratory diseases. Significant contributions to understanding and treating sepsis emerged in 2013. The role of tissue damage was highlighted in a series of publications. A much greater understanding of the importance of pathways that directly impact the pathogen at the site of infection and subsequent pathogen clearance has emerged. The Journal published important contributions across the spectrum of ineffective therapy (activated protein C), novel therapeutic ideas (statins and extracorporeal membrane oxygenation), and solidly beneficial approaches (early protocolized care). Biomarker development is maturing to include a wide array of molecular measurements increasingly aimed at aiding improved therapy.

AB - The Journal has been in the vanguard of publications of the respiratory microbiome, including a National Institutes of Health Workshop report, establishing the normal microbiome in patients with various risks, and in the correlation of microbiome changes with disease exacerbations and lung transplant. A new classification scheme for healthcare-associated pneumonia, risks for nosocomial Pseudomonas pneumonia, and associations between communityacquired pneumonia and risks or outcomes have been reported. The increasingly recognized role of viral respiratory tract infections was reflected in publications regarding incidence rates, risk factors, and associations with other respiratory diseases. Significant contributions to understanding and treating sepsis emerged in 2013. The role of tissue damage was highlighted in a series of publications. A much greater understanding of the importance of pathways that directly impact the pathogen at the site of infection and subsequent pathogen clearance has emerged. The Journal published important contributions across the spectrum of ineffective therapy (activated protein C), novel therapeutic ideas (statins and extracorporeal membrane oxygenation), and solidly beneficial approaches (early protocolized care). Biomarker development is maturing to include a wide array of molecular measurements increasingly aimed at aiding improved therapy.

KW - Biomarkers

KW - Microbiome

KW - Pneumonia

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=84903829354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903829354&partnerID=8YFLogxK

U2 - 10.1164/rccm.201403-0577UP

DO - 10.1164/rccm.201403-0577UP

M3 - Article

C2 - 24983219

AN - SCOPUS:84903829354

VL - 190

SP - 25

EP - 31

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -